NAC
ABBV icon

NI Acquisitions Company’s AbbVie ABBV Stock Holding History

NI Acquisitions Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Buy
+1,052
New +$226K 0.05% 96

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

NI Acquisitions Company's ABBV Position: Q2 2026 in Review

NI Acquisitions Company opened a new position in AbbVie (ABBV) in Q2 2026: 1,052 shares worth $113K. The stake represents 0.05% of the portfolio and ranks #96 among its holdings.

4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • NI Acquisitions Company held 1,052 shares of AbbVie worth $113K as of Q2 2026.
  • AbbVie was a new NI Acquisitions Company position in Q2 2026.
  • AbbVie made up 0.05% of NI Acquisitions Company's portfolio in Q2 2026, its #96 holding.
  • 4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on NI Acquisitions Company's 13F filing for Q2 2026, filed 5 Aug 2026.